Next generation sequencing as a tool for pharmacogenomic profiling: Nine novel potential genetic markers for targeted therapy in childhood acute lymphoblastic leukemia
Introduction/Objective. Next generation sequencing (NGS) technology has enabled genomic profiling of each patient. Growing knowledge in pharmacogenomics makes it possible to use NGS data for discovery of novel potential genetic markers for targeted therapy of many diseases, especially cancers. The a...
Main Authors: | Dokmanović Lidija, Milošević Goran, Perić Jelena, Tošić Nataša, Krstovski Nada, Janić Dragana, Pavlović Sonja |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2018-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2018/0370-81791700194D.pdf |
Similar Items
-
Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia
by: Janic Dragana, et al.
Published: (2020-01-01) -
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
by: Nikola Kotur, et al.
Published: (2020-04-01) -
Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy
by: Dokmanović Lidija, et al.
Published: (2008-01-01) -
Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia
by: Lazić Jelena, et al.
Published: (2009-01-01) -
Lymphoblastic lymphomas in children: A single-center experience from Serbia
by: Lazić Jelena, et al.
Published: (2016-01-01)